What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.41%Below 5Y avg (2.50%)
Annual Rate
CNY 0.02Paid annual
Payout Ratio
118.2%High
Last Ex-Dividend
May 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.72BCNY
1.16B · vs all stocks (USD)
Updated Oct 23, 2026
Revenue (TTM)
18.03BCNY
2.70B · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
-2.95%
Updated Oct 23, 2026
Beta
0.2940x
vs all stocks
Updated Oct 23, 2026
52-Week Change
-32.92%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
7.72BCNY
1.16B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
8.72BCNY
1.31B · vs all stocks (USD)
Updated Oct 23, 2026
Forward P/E
4.33x
Updated Oct 23, 2026
Price to Sales (TTM)
0.4385x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.43×.Updated Oct 23, 2026
Price to Book (MRQ)
0.5863x
Updated Oct 23, 2026
Enterprise to Revenue
0.4840x
Updated Oct 23, 2026
Enterprise to EBITDA
37.38x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 7.56×.Updated Oct 23, 2026
Gross Margin
7.26%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 5.12%.Updated Oct 23, 2026
Profit Margin
-2.95%
Updated Oct 23, 2026
Operating Margin
-0.77%
Updated Oct 23, 2026
Return on Assets (TTM)
-1.71%
Updated Oct 23, 2026
Return on Equity (TTM)
-3.92%
Updated Oct 23, 2026
Revenue (TTM)
18.03BCNY
2.70B · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
11.26CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
16.90%
Updated Oct 23, 2026
Gross Profit (TTM)
923.10MCNY
138.36M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
1.15BCNY
172.95M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
-531.24MCNY
-79.63M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
11.55%
Updated Oct 23, 2026
Operating Cash Flow (TTM)
-231.62MCNY
-34.72M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
205.78MCNY
30.84M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing Annual Dividend Rate
0.0200CNYUpdated Oct 23, 2026
Trailing Annual Dividend Yield
0.41%
vs all stocks
Updated Oct 23, 2026
5-Year Average Dividend Yield
2.50%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
118.18%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -5.88%.Updated Oct 23, 2026
Minority Interest (Equity)
1.01BCNYFY2025 · Dec 31, 2025
Revenue
17.39BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
15.74BCNYFY2025 · Dec 31, 2025
Gross Profit
1.65BCNYFY2025 · Dec 31, 2025
Operating Income
23.24MCNY
3.48M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-38.59MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-12.61MCNYFY2025 · Dec 31, 2025
Net Income
-25.98MCNYFY2025 · Dec 31, 2025
EBIT
100.60MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.15BCNYFY2025 · Dec 31, 2025
Research & Development
506.41MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
164.38MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
310.52MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
88.38MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
139.19MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.0200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.0200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.62BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.62BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-25.98MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-6.39MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
164.12MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-596.24MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
5.48BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-25.98MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
188.03MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
540.15MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-538.08MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-760.36MCNYFY2025 · Dec 31, 2025
Sale of Investments
133.34MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-627.02MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.50BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-4.37BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-543.26MCNYFY2025 · Dec 31, 2025
Other Financing Charges
82.90MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
664.67MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.59BSharesUpdated Oct 23, 2026
Float Shares
487.79MSharesUpdated Oct 23, 2026
% Held by Insiders
48.12%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
30.02%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
5.18BCNY
776.71M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
3.26CNYUpdated Oct 23, 2026
Total Debt (MRQ)
5.05BCNY
756.96M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.3499x
Updated Oct 23, 2026
Current Ratio (MRQ)
0.9990x
Updated Oct 23, 2026
Book Value per Share (MRQ)
8.49CNYUpdated Oct 23, 2026
Total Assets
25.83BCNY
3.87B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
9.70BCNYFY2025 · Dec 31, 2025
Total Liabilities
11.18BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
16.12BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.87BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
9.32BCNYFY2025 · Dec 31, 2025
Cash
1.86BCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.62BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
5.48BCNYFY2025 · Dec 31, 2025
Accounts Receivable
607.10MCNYFY2025 · Dec 31, 2025
Inventory
1.54BCNYFY2025 · Dec 31, 2025
Accounts Payable
3.79BCNYFY2025 · Dec 31, 2025
Short-term Debt
3.66BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.16BCNYFY2025 · Dec 31, 2025
Long-term Debt
741.80MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
616.60MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.59BCNYFY2025 · Dec 31, 2025
Retained Earnings
7.95BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
14.64BCNY
2.19B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.61CNYUpdated Oct 23, 2026
52-Week High
7.35CNYUpdated Oct 23, 2026
52-Week Change
-32.92%
vs all stocks
Updated Oct 23, 2026
Beta
0.2940x
vs all stocks
Updated Oct 23, 2026
50-Day MA
5.37CNYUpdated Oct 23, 2026
200-Day MA
5.68CNYUpdated Oct 23, 2026
Avg 10-Day Volume
10.88MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
11.64MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
-0.3400CNYUpdated Oct 23, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has compounded over six years while gross profit and net income fell over four.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.55: grey zoneSignificant
Altman Z-Score: 1.55
High earnings qualityNotable
Earnings Quality Score: 0.56
Supply Chain
Upstream position: supplies 4 industries, depends on 1Notable
Outgoing: 4.00Incoming: 1.00
Scale
Market cap is $1.16B, above the global median of $1.14BNotable
Market cap (USD): 1,156,657,253.45Global Median: 1,137,180,293.291
Revenue is $2.7B, above the global median of $566.17MNotable